eMedicine Specialties > Dermatology > Diseases of the Adnexa

Disseminate and Recurrent Infundibular Folliculitis

Author: Stephen W White, MD, Clinical Assistant Professor, Department of Dermatology, George Washington University Hospital; Chief, Sub-section of Dermatology, Suburban Hospital
Coauthor(s): Christopher R Gorman, MD, Bethesda Dermatology, private practice
Contributor Information and Disclosures

Updated: Oct 30, 2009

Introduction

Background

Disseminate and recurrent infundibular folliculitis (DRIF) was first described in 1968 by Hitch and Lund.1 The clinical presentation is much like miliaria or keratosis pilaris. It is mostly seen in young healthy people, and most patients have a dark skin color. It consists of generalized flesh-colored papules. Therapy has generally been unsuccessful.

Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.

Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.


The validity of disseminate and recurrent infundibular folliculitis as a separate entity has been questioned. However, it does have such a characteristic clinical picture that for the present it is accepted as an entity.

Pathophysiology

The etiology of disseminate and recurrent infundibular folliculitis is not established.

Frequency

United States

Although the first case of disseminate and recurrent infundibular folliculitis was not reported until 1968, other more recent reports indicate that it is a fairly common occurrence. Clinics that see a large number of young dark-skinned patients report that disseminate and recurrent infundibular folliculitis is a common condition. Indeed, it may occur in large numbers in hot, humid weather.

International

Cases of disseminate and recurrent infundibular folliculitis have been reported from Europe and India.

Mortality/Morbidity

Pruritus is the troublesome symptom of disseminate and recurrent infundibular folliculitis. In the past, this was difficult to relieve. The condition may be recurrent over a number of years. Disseminate and recurrent infundibular folliculitis may make it uncomfortable for the patient to work in a hot, humid environment.

Race

Disseminate and recurrent infundibular folliculitis has been reported primarily in people of African American origin in the United States.2 Why a number of dermatoses tend to be papular and follicular in dark-skinned people is not known. This phenomenon is well documented in atopic dermatitis.

Sex

Although most of the patients are men, disseminate and recurrent infundibular folliculitis has been reported in women.

Age

Most of the reported disseminate and recurrent infundibular folliculitis patients have been healthy young adults.

Clinical

History

  • Most patients report a sudden onset of a widespread pruritic papular eruption.
  • Disseminate and recurrent infundibular folliculitis has been reported to be exacerbated by hot showers and relieved by anything that cools (eg, cool showers, lotions, swimming).
  • Occasionally, a patient may report that a number of peers have been affected at the same time.
  • Often, disseminate and recurrent infundibular folliculitis patients have a personal or family history of atopy.

Physical

  • Physical examination in disseminate and recurrent infundibular folliculitis reveals a papular eruption that has a follicular location.
  • In a given area, all the follicles are involved, with no skipping of any follicles in the area involved.
  • The usual sites are the chest and mantle and the upper arms.
  • Infundibular folliculitis is rather monomorphic without noted rubor, calor, and dolor.
Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.

Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.


Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.

Courtesy of San Antonio Uniformed Services Health...

Courtesy of San Antonio Uniformed Services Health Education Consortium slide files.


Causes

  • The exact cause of disseminate and recurrent infundibular folliculitis is unknown.
  • The history often suggests a hot, humid environment as a precipitating cause.
  • Once established, disseminate and recurrent infundibular folliculitis tends to persist or recur over a prolonged period.

More on Disseminate and Recurrent Infundibular Folliculitis

Overview: Disseminate and Recurrent Infundibular Folliculitis
Differential Diagnoses & Workup: Disseminate and Recurrent Infundibular Folliculitis
Treatment & Medication: Disseminate and Recurrent Infundibular Folliculitis
Follow-up: Disseminate and Recurrent Infundibular Folliculitis
Multimedia: Disseminate and Recurrent Infundibular Folliculitis
References

References

  1. Hitch JM, Lund HZ. Disseminate and recurrent infundibulo-folliculitis: report of a case. Arch Dermatol. Apr 1968;97(4):432-5. [Medline].

  2. Barriere H, Litoux P, Bureau B, Stalder JF. [Disseminate and recurrent infundibulo-folliculitis (Hitch and Lund)]. Ann Dermatol Venereol. Apr 1980;107(4):299-302. [Medline].

  3. Hinds GA, Heald PW. A case of disseminate and recurrent infundibulofolliculitis responsive to treatment with topical steroids. Dermatol Online J. Nov 15 2008;14(11):11. [Medline].

  4. Ravikumar BC, Balachandran C, Shenoi SD, Sabitha L, Ramnarayan K. Disseminate and recurrent infundibulofolliculitis: response to psoralen plus UVA therapy. Int J Dermatol. Jan 1999;38(1):75-6. [Medline].

  5. Aroni K, Grapsa A, Agapitos E. Disseminate and recurrent infundibulofolliculitis: response to isotretinoin. J Drugs Dermatol. Jul-Aug 2004;3(4):434-5. [Medline].

  6. Owen WR, Wood C. Disseminate and recurrent infundibulofolliculitis. Arch Dermatol. Feb 1979;115(2):174-5. [Medline].

  7. El Shabrawi-Caelen L, Soyer HP. Clinical Pathologic Challenge: Patchy pityriasiform lichenoid eczema. Am J Dermatopathol. Jun 2005;27(3):216, 258.

  8. White SW, Rodman OG. Disseminate and recurrent infundibulofolliculitis. J Assoc Military Dermatol. 1981;22-23.

Further Reading

Keywords

disseminate and recurrent infundibular folliculitis, DRIF, disseminate and recurrent infundibulofolliculitis, recurrent disseminated infundibulofolliculitis, infundibulofolliculitis disseminate and persistent infundibulofolliculitis

Contributor Information and Disclosures

Author

Stephen W White, MD, Clinical Assistant Professor, Department of Dermatology, George Washington University Hospital; Chief, Sub-section of Dermatology, Suburban Hospital
Stephen W White, MD is a member of the following medical societies: American Academy of Dermatology, International Society of Dermatology, Society for Investigative Dermatology, and Society for Pediatric Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

Christopher R Gorman, MD, Bethesda Dermatology, private practice
Christopher R Gorman, MD is a member of the following medical societies: Alpha Omega Alpha
Disclosure: Nothing to disclose.

Medical Editor

James Fulton Jr, MD, PhD, Center for Cosmetic Dermatology; Consultant, Vivant Pharmaceuticals, LLC
James Fulton Jr, MD, PhD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American Society for Laser Medicine and Surgery, Dermatology Foundation, International Society of Cosmetic and Laser Surgeons, and Skin Cancer Foundation
Disclosure: vivant pharmaceuticals Ownership interest Consulting

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Catherine M Quirk, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania
Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.